Atlas Trials

Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations

Clinical trial NCT03624101 · TERMINATED

Trial details

NCT number
NCT03624101
Sponsor
University of Alabama at Birmingham
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2018-12-01
Primary completion
2019-10-03
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.